ChartRow logo
ChartRow
Investing Charts
AMGN
Amgen Inc.Stock · HealthcareDow Jones 4.3% · Nasdaq-100 1.1% · S&P 500 0.3%
$376.04+$4.54 (+1.22%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

AMGNAmgen Inc. stock price, chart and key statistics

Key stats

Price data

Price
$376.04
Change YTD
+14.77%
Next earnings
Aug 4, 2026 · After close
Market cap
203B
Enterprise value
242.8B
Shares outstanding
539.7M
52W low
$269.77
52W high
$391.29
From 52W high
-3.90%
From 52W low
+39.39%
52W range
87%
Beta
0.40

Volume

Rel volume
1.36×
30D volume
2.7M
30D $ vol
969.4M

Fundamentals

Sales (ttm)
37.2B
Sales/share
$68.96
EPS (ttm)
$14.34
FCF (ttm)
8.6B
FCF/share
$15.93
Book value/share
$17.03
Net margin
20.96%
ROE
84.87%
ROA
8.43%
Debt / equity
5.65×
Current ratio
1.26

Growth (CAGR, ttm) · 10Y

Sales
+5.33%
Net income
+0.78%
FCF
-1.03%
Shares
-3.25%

Per-share growth (CAGR, ttm) · 10Y

EPS
+4.25%
Sales/share
+8.87%
FCF/share
+2.30%
Book value/share
-7.76%
Dividend/share
+11.27%
Price
+8.54%
Total return
+11.80%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
26.0×
Fwd P/E
15.7×
P/S (ttm)
5.5×
P/B (mrq)
22.1×
P/FCF (ttm)
23.6×
EV/EBITDA (fy)
17.0×
EV/Sales (ttm)
6.5×
FCF yield (ttm)
4.24%
Dividend yield (fwd)
2.68%
Dividend/share (fwd)
$10.08
Buyback yield (ttm)
0.00%
Shareholder yield (ttm)
2.56%

Vs own 10Y history

P/E
78th
P/S
69th
P/B
73rd
P/FCF
94th

Bar = where today's multiple sits in AMGN's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+1.22%
1W
+2.66%
1M
+7.00%
3M
+7.87%
YTD
+14.77%
1Y
+21.61%
5Y
+51.65%

Financial statements

Open full AMGN financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B
GILD
Gilead Sciences Inc.
Biotech$129+3.32%976.5M

Amgen Inc. (AMGN) trades at $376.04 with a live price and an interactive chart covering 42+ years of daily price history, plus key valuation metrics. ChartRow also publishes AMGN's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full AMGN financial statements →